Notice: This company has been marked as potentially delisted and may not be actively trading. Loxo Oncology (LOXO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period BlossomHill Therapeutics Appoints Geoff Oxnard, M.D., as Chief Medical Officer and Executive Vice PresidentJanuary 6, 2025 | finance.yahoo.comQ3 2024 Eli Lilly and Co Earnings CallNovember 1, 2024 | finance.yahoo.comSwitching jobs? There's more to do with your 401(k) than just rolling it overOctober 25, 2024 | msn.comWalmart agrees to pay $7.5 million to settle California lawsuit over disposal of hazardous wasteOctober 24, 2024 | greenwichtime.comNew rules for US national security agencies balance AI's promise with need to protect against risksOctober 24, 2024 | greenwichtime.com2008 to 2022 Saw Rise in Industry-Sponsored Adult Cancer Clinical TrialsOctober 16, 2024 | msn.comChemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030October 14, 2024 | uk.finance.yahoo.comIs Eli Lilly and Company (LLY) the Best Cancer Stock to Buy Now?September 4, 2024 | insidermonkey.comGlobal Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsightAugust 22, 2024 | finance.yahoo.comMantle Cell Lymphoma Treatment Market is Projected to Reach US$ 5.77 Billion by 2034, with a 8.6% CAGR | Fact.MR ReportAugust 16, 2024 | finance.yahoo.comStudy: Integration of pharmacies with physician practices has little impact on cancer drug expendituresMay 24, 2024 | msn.comTyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of DirectorsMay 7, 2024 | finance.yahoo.comEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call TranscriptMay 2, 2024 | msn.comEli Lilly (LLY) Q1 2024 Earnings Call TranscriptApril 30, 2024 | msn.comGlobal CLL Therapeutics Market Set to Reach $9.2 Billion by 2032March 25, 2024 | finance.yahoo.comMOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business OfficerMarch 11, 2024 | finance.yahoo.comDavid M Mott's Net WorthFebruary 26, 2024 | benzinga.comFoghorn gets $300M plus investment from Lilly under cancer drug partnershipFebruary 8, 2024 | bizjournals.comEli Lilly’s Jaypirca to lead BTK inhibitor market for leukemiaJanuary 18, 2024 | msn.comIron Condor Alert: LLY Stock Could Net 40% In 4 WeeksJanuary 10, 2024 | msn.cominsitro Hires Chief Medical Officer to Advance Therapeutic Programs Toward the ClinicJanuary 8, 2024 | finance.yahoo.comFoghorn Therapeutics Highlights Clinical Program Updates and Research Progress and Provides Strategic Objectives for 2024January 8, 2024 | markets.businessinsider.comEli Lilly surprised as POINT Biopharma acquisition remains incompleteDecember 5, 2023 | msn.comLilly cancer drug cleared by FDA for expanded leukemia, lymphoma useDecember 4, 2023 | finance.yahoo.comEli Lilly and Company (NYSE:LLY) Q3 2023 Earnings Call TranscriptNovember 4, 2023 | finance.yahoo.comFoghorn Therapeutics, Inc.: Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate UpdateNovember 2, 2023 | finanznachrichten.deCiti continue to see upside to Eli Lilly & Co.'s 'already rich' valuationNovember 2, 2023 | ca.investing.comFoghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate UpdateNovember 2, 2023 | finance.yahoo.comLilly agrees to buy POINT Biopharma for $1.4bnOctober 4, 2023 | msn.comEli Lilly to pay $1.4-billion for cancer-drug maker Point BiopharmaOctober 4, 2023 | msn.comPoint Biopharma stock soars on $1.4B takeover bid from Eli LillyOctober 3, 2023 | thestreet.comPOINT Biopharma (NASDAQ: PNT) Soars After Eli Lilly’s $1.4 Billion AcquisitionOctober 3, 2023 | msn.comEli Lilly to Pay $1.4 Billion for Cancer-Drug Maker Point BiopharmaOctober 3, 2023 | msn.comEli Lilly Acquiring Cancer Therapy Developer For $1.4 Billion—A Nearly 90% PremiumOctober 3, 2023 | msn.comBiocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leadersSeptember 26, 2023 | finanznachrichten.dePress Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leadersAugust 28, 2023 | finance.yahoo.comPropulsion of Medullary Thyroid Cancer Clinical Trial Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Domain | DelveInsightAugust 25, 2023 | benzinga.comNext-generation study launched via LSUHS partnership to aid rural cancer patientsAugust 16, 2023 | msn.comBiocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla PlatformAugust 10, 2023 | finanznachrichten.dePress Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ PlatformAugust 10, 2023 | finance.yahoo.comQ2 2023 Eli Lilly and Co Earnings CallAugust 9, 2023 | finance.yahoo.comMerus Announces Financial Results for the Second Quarter 2023 and Provides Business UpdateAugust 8, 2023 | benzinga.comCircle Pharma strengthens its executive leadership team with two senior appointments in Clinical DevelopmentJuly 26, 2023 | venturebeat.comGlobal Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel GrowthMay 16, 2023 | benzinga.comLoxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual MeetingMay 11, 2023 | markets.businessinsider.com8-K: Foghorn Therapeutics Inc.May 8, 2023 | marketwatch.comEli Lilly (LLY) Q1 2023 Earnings Call TranscriptApril 28, 2023 | msn.comQ1 2023 Eli Lilly and Co Earnings CallApril 28, 2023 | finance.yahoo.comBruton's Tyrosine Kinase (BTK) Inhibitors Market Report Provide in Depth Analysis of Key Drivers 2023-2030April 12, 2023 | marketwatch.comThe Pemetrexed Drug market analysis report examines the industry's growth trajectory from 2023 to 2030, with a CAGR valuation of 7.6%.April 10, 2023 | marketwatch.com Get Loxo Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for LOXO and its competitors with MarketBeat's FREE daily newsletter. Email Address LOXO Media Mentions By Week LOXO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LOXO News Sentiment▼0.000.71▲Average Medical News Sentiment LOXO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LOXO Articles This Week▼00▲LOXO Articles Average Week Get Loxo Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for LOXO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Teva Pharmaceutical Industries News Today Royalty Pharma News Today BeiGene News Today Summit Therapeutics News Today United Therapeutics News Today Insmed News Today Intra-Cellular Therapies News Today Viatris News Today Genmab A/S News Today BioMarin Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LOXO) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Loxo Oncology Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Loxo Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
